English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/127053
logo share SHARE   Add this article to your Mendeley library MendeleyBASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:


CD2 deficient african swine fever virus as live attenuated or subsequently inactivated vaccine against african swine fever in mammals

AuthorsRodríguez, Fernando; Salas, María Luisa
Issue Date25-Jun-2015
AbstractThe present invention is directed to a preferably live attenuated or subsequently inactivated African swine fever virus (ASFV), comprising a non-functional genomic CD2 gene, wherein such ASFV is not deficient in its replication, as well as to corresponding compositions or immunogenic compositions or vaccines, methods of production and uses for treating and/or preventing African swine fever in mammals, preferably of the family Suidae, for instance pigs, more preferably domestic pigs (Sus scrofa domesticus), wild pigs (Sus scrofa scrofa), warthogs (Potamochoerus porcus), bushpigs (Potamochoerus larvatus), giant forest hogs (Hylochoerus meinertzhageni) as well as feral pigs.
Appears in Collections:(CBM) Patentes
Files in This Item:
File Description SizeFormat 
WO2015091322_A1.pdf64,08 kBAdobe PDFThumbnail
Show full item record
Review this work

WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.